Venus Remedies gets huge global acclaim with UNICEF GMP approval
Venus Remedies Limited, a leading global pharmaceutical company, has recently secured Good Manufacturing Practices (GMP) approval from the United Nations International Children’s Emergency Fund (UNICEF). This milestone underscores Venus Remedies’ commitment to delivering top-quality pharmaceutical solutions worldwide. Venus Remedies’ manufacturing…
Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced positive comparative microbiology and microbiome data for ibezapolstat, its lead antibiotic candidate, from the Company’s recently…
Could a Phytochemical derived from Vegetables like Broccoli be the Answer to Antibiotic Resistant Pathogens
Antibiotic-resistant bacterial pathogens are increasingly playing a role in rising illness and preventing wound healing, especially in hospitals. While more and more pathogens have developed biofilms that protect them from being eradicated by antibiotics, fewer classes of antibiotics are being…